Previous in vitro and in vivo studies have shown that versican enhances cancer cell survival, growth, migration, invasion, angiogenesis, drug resistance, and metastasis and has been shown to induce malignancy in OS cells through the interaction with TGF-beta (29–33). This evidence concerns the gene VCAN and cancer.